首页> 外国专利> NOVEL EOSINOPHIL CATIONIC PROTEINS USED IN THE TREATMENT OF ASTHMATIC AND ALLERGIC DISORDERS

NOVEL EOSINOPHIL CATIONIC PROTEINS USED IN THE TREATMENT OF ASTHMATIC AND ALLERGIC DISORDERS

机译：新型嗜酸性阳离子蛋白用于哮喘和过敏性疾病的治疗

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to novel eosinophil cationic proteins characterised by the presence of a single nucleotide polymorphism. The presence of such polymorphism has been correlated to an advantageous phenotype being a reduced disposition to allergic and asthmatic disorders.

机译：本发明涉及新颖的嗜酸性粒细胞阳离子蛋白，其特征在于存在单核苷酸多态性。这种多态性的存在已经与有利的表型相关，该表型是变应性和哮喘疾病的减少的原因。

著录项

公开/公告号WO0185766A3

专利类型
公开/公告日2002-04-18

原文格式PDF
申请/专利权人 INNOVENTUS PROJECT AB;HOEGBOM ERIK;BYSTROEM JONAS;JOENSSON ULLA-BRITT;VENGE PER;
展开▼

申请/专利号WO2001IB00927
发明设计人 HOEGBOM ERIK;BYSTROEM JONAS;JOENSSON ULLA-BRITT;VENGE PER;
展开▼

申请日2001-05-08
分类号C07K14/47;C12N9/22;C12Q1/68;A61K38/46;A61P11/06;
国家 WO
入库时间 2022-08-22 00:38:16

相似文献

专利
外文文献
中文文献